These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4610017)

  • 1. Sisomicin treatment of complicated urinary tract infections: efficacy, tolerance and pharmacokinetics.
    Welling PG; Mosegaard A; Madsen PO
    J Clin Pharmacol; 1974 Oct; 14(10):567-73. PubMed ID: 4610017
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment.
    Westenfelder SR; Welling G; Madsen PO
    Infection; 1974; 2(2):76-9. PubMed ID: 4842961
    [No Abstract]   [Full Text] [Related]  

  • 3. Tobramycin, a new aminoglycoside antibiotic: Experience in urinary tract infections.
    Landes RR; Melnick I; Hoffman A; Fehrenbaker L
    South Med J; 1975 Jan; 68(1):116-7. PubMed ID: 125452
    [No Abstract]   [Full Text] [Related]  

  • 4. Tobramycin: clinical and microbiological evaluation.
    Schoutens E; Vanderlinden MP; Yourassowsky E
    Int J Clin Pharmacol; 1973 Nov; 8(3):207-15. PubMed ID: 4589328
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary tract infections due to multiresistant gram negative bacteria].
    Acar JF; Guibert J; Bourquelot P; Brisset JM
    Nouv Presse Med; 1974 Apr; 3(0):69-72. PubMed ID: 4209339
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
    Fraschini F; Scaglione F; Alessandria M; Gattei G
    Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with sisomicin of complicated urinary tract infections in patients with varying degrees of renal function impairment, pharmacokinetics and dosage adjustment.
    Mosegaard A; Welling PG; Tse FL; Madsen P
    Infection; 1975; 3(3):143-7. PubMed ID: 1223005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on intravenous drip-infusion of micronomicin for complicated urinary tract infections].
    Kumon H; Ohmori H
    Jpn J Antibiot; 1984 Aug; 37(8):1445-52. PubMed ID: 6502931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection.
    Roth S; Naber K; Scheer M; Gruenwaldt G; Lange H
    Eur J Clin Pharmacol; 1976 Sep; 10(5):357-65. PubMed ID: 789084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies of intravenous drip infusion of micronomicin. Urinary tract infections].
    Kawamura N
    Jpn J Antibiot; 1984 Jan; 37(1):122-35. PubMed ID: 6374191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory studies with tobramycin.
    Geddes AM; Goodall JA; Speirs CF; Gillett AP; Andrews J; Williams JD
    Chemotherapy; 1974; 20(4):245-56. PubMed ID: 4212996
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sisomycin--comparative pharmacokinetic studies and clinical experiences with a new aminoglycoside antibiotic].
    Lode H; Kemmerich B; Langmaack H
    Verh Dtsch Ges Inn Med; 1975; 81():1646-8. PubMed ID: 1227044
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of complicated urinary tract infections. Comparative study of sisomicin and gentamicin.
    Madsen PO; Kjaer TB; Mosegaard A
    Urology; 1977 Jun; 9(6):635-8. PubMed ID: 329522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections.
    Stamey TA; Fair WR; Timothy MM; Millar MA; Mihara G; Lowery YC
    N Engl J Med; 1974 Nov; 291(22):1159-63. PubMed ID: 4422010
    [No Abstract]   [Full Text] [Related]  

  • 15. The value of antibiotic levels in tissue and in urine in the treatment of urinary tract infections.
    Naumann P
    J Antimicrob Chemother; 1978 Jan; 4(1):9-17. PubMed ID: 342484
    [No Abstract]   [Full Text] [Related]  

  • 16. A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis.
    Connolly LE; Riddle V; Cebrik D; Armstrong ES; Miller LG
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials.
    Vidal L; Gafter-Gvili A; Borok S; Fraser A; Leibovici L; Paul M
    J Antimicrob Chemother; 2007 Aug; 60(2):247-57. PubMed ID: 17562680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
    Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
    Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
    [No Abstract]   [Full Text] [Related]  

  • 19. Sisomicin in urinary tract infection: Tolerance and efficacy study.
    Etra W; Surgalla M; Wajsman Z; Baumgartner G; Merrin C
    Urology; 1976 Feb; 7(2):160-4. PubMed ID: 1246785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of combination therapy with Fortimicin and Cefotax in the treatment of complicated urinary tract infections].
    Sakashita S; Asano Y; Togashi M; Maru A; Koyanagi T; Kasai T; Namiji T; Mitsuhashi K; Amino I; Kaneta T
    Hinyokika Kiyo; 1987 Oct; 33(10):1718-23. PubMed ID: 3328504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.